CVE-2023-31167: Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')
Schweitzer Engineering Laboratories · SEL-5036 acSELerator Bay Screen Builder Software
Fixed in 1.0.49152.778 · Affected: Schweitzer Engineering Laboratories SEL-5036 acSELerator Bay Screen Builder Software before 1.0.49152.778 · Exploitation: unlikely (under 1%)
Not in CyberSIXT coverage yet: no article names this CVE. This page shows the public record.
Higher than 37% of scored CVEs
DescriptionCVE.org
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Schweitzer Engineering Laboratories SEL-5036 acSELerator Bay Screen Builder Software on Windows allows Relative Path Traversal. SEL acSELerator Bay Screen Builder software is distributed by SEL-5033 SEL acSELerator RTAC, SEL-5030 Quickset, and SEL Compass. CVE-2023-31167 and was patched in the acSELerator Bay Screen Builder release available on 20230602. Please contact SEL for additional details. This issue affects SEL-5036 acSELerator Bay Screen Builder Software: before 1.0.49152.778.
Affected products1
From the CVE record. A product or version that is not listed is unknown, not unaffected.
- Schweitzer Engineering Laboratories · SEL-5036 acSELerator Bay Screen Builder Softwarebefore 1.0.49152.778
On the Atlas
Every published CVE is on the CyberSIXT Atlas, grouped by weakness, vendor and month.
- Exploitation
- Unlikely (under 1%). EPSS under 1%, or no score yet.
- CISA KEV
- Not listed
- Public check
- No public nuclei template
- Published
- August 2023
CoverageNo articles yet
No CyberSIXT article names CVE-2023-31167 yet, so there is no coverage timeline, action brief or change log for it. Everything on this page comes from the public CVE record, CISA KEV, EPSS and the nuclei template index. Search the archive or see the CVEs in the news.